Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan
**Background:** Antimicrobial resistance (AMR) represents a significant global public health crisis. Despite ample availability of Gram-positive antibiotics, there is a distinct lack of agents against Gram-negative pathogens, including carbapenem-resistant Enterobacterales, which remains a real thre...
Saved in:
Main Authors: | Tetsuya Matsumoto, Oliver Darlington, Ryan Miller, Jason Gordon, Phil McEwan, Takahisa Ohashi, Amer Taie, Akira Yuasa |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2021-10-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.28327 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unseen Enemy: Mechanisms of Multidrug Antimicrobial Resistance in Gram-Negative ESKAPE Pathogens
by: Giedrė Valdonė Sakalauskienė, et al.
Published: (2025-01-01) -
Identifying Opportunity Targets in Gram-Negative Pathogens for Infectious Disease Mitigation
by: Isaac A. Paddy, et al.
Published: (2025-01-01) -
Environmental microbial communications in gram-positive and gram-negative bacteria
by: P. Srikanth, et al.
Published: (2023-11-01) -
The Threat of the Emergence of Antimicrobial-Resistant Gram-Positive Pathogens in Canada
by: Donald E Low, et al.
Published: (1994-01-01) -
Carbapenem resistance in gram-negative pathogens in an Iranian hospital: high prevalence of OXA-type carbapenemase genes
by: Setareh Mamishi, et al.
Published: (2025-01-01)